The management of the Berlin-based manufacturer of high-tech laboratory instruments reports on current plans to ensure sustainable business success.

The Business Angels Club Berlin-Brandenburg has been supporting startup founders in building their own companies for more than 20 years.

Scientists from the Massachusetts Institute of Technology (USA) and Freie Universität combined a mixture of mucilaginous and sticky proteins to produce an adhesive for biomedical applications / Results published in renowned journal PNAS

There are more than 60 robotics companies in the Berlin region. In addition, numerous research institutions and projects are devoted to the topic. The Berlin-Brandenburg Robotics Network, borne by the Berlin Partner Business Location Center, is an…

Deadline: March 31st, 2025

Bürkert Fluid Control Systems has taken a stake in Green Elephant Biotech as a strategic investor so the two companies can work together to develop more efficient, flexible and sustainable cell cultivation processes in the pharmaceutical and biotech…

There is currently no drug approved worldwide for the treatment of sudden hearing loss. However, preclinical and clinical phase-1-studies with the innovative drug candidate AC102 have been promising. AudioCure Pharma, a Berlin-based start-up…

Dr. Maik Pietzner receives a W2 professorship for life for “Health Data Modeling” at the Berlin Institute of Health at Charité (BIH). His aim is to find disease-specific small changes in genes and thus target structures for innovative drugs. Using…

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response in the region changes, researchers from Berlin and Heidelberg report in “Science Immunology.” The detailed insights into…

- Ac-satoreotide is a first-in-class Actinium-labelled somatostatin receptor 2 antagonist targeting extensive-stage Small Cell Lung Cancer or Merkel Cell Carcinoma

- Orphan Drug Designation follows outstanding preclinical data and FDA IND…